He Zhang

Dr. He Zhang

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2021 in Clinical Biochemistry
Verified
Journal Article
Closed access
YZYanhua Zhao
Yanhua Zhao
SWSiming Wang
Siming Wang
SLShanshan Liang
Shanshan Liang
HZHe Zhang
He Zhang
YZYanxing Zhang
Yanxing Zhang
WGWei Gan
Wei Gan

21 March 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
YZYalan Zhu
Yalan Zhu
HZHe Zhang
He Zhang
PJPengjun Jiang
Pengjun Jiang
CXChengxia Xie
Chengxia Xie
Yao LuoYao Luo
Yao Luo
JCjie chen
jie chen
Non-alcoholic fatty liver disease (NAFLD) encompasses a broad spectrum of conditions from simple steatosis (non-alcoholic fatty liver (NAFL)) to non-alcoholic steatohepatitis (NASH), and its global prevalence continues to rise. NASH, the progressive form of NAFLD, has higher risks of liver and non-liver related adverse outcomes compared with those patients with NAFL alone. Therefore, the present study aimed to explore the mechanisms in the progression of NAFLD and to develop a model to diagnose NASH based on the transcriptome and epigenome. Differentially expressed genes (DEGs) and differentially methylated genes (DMGs) among the three groups (normal, NAFL, and NASH) were identified, and the functional analysis revealed that the development of NAFLD was primarily related to the oxidoreductase-related activity, PPAR signaling pathway, tight junction, and pathogenic Escherichia coli infection. The logistic regression (LR) model, consisting of ApoF, THOP1, and BICC1, outperformed the other five models. With the highest AUC (0.8819, 95%CI: 0.8128–0.9511) and a sensitivity of 97.87%, as well as a specificity of 64.71%, the LR model was determined as the diagnostic model, which can differentiate NASH from NAFL. In conclusion, several potential mechanisms were screened out based on the transcriptome and epigenome, and a diagnostic model was built to help patient stratification for NAFLD populations.

4 October 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
SSShiya Shi
Shiya Shi
ZZZhouyanjie Zhou
Zhouyanjie Zhou
HZHe Zhang
He Zhang
YZYalan Zhu
Yalan Zhu
PJPengjun Jiang
Pengjun Jiang
JCjie chen
jie chen
Background: Observational studies have highlighted the pivotal role of inflammatory cytokines in cirrhosis progression. However, the existence of a causal link between inflammatory cytokines and cirrhosis remains uncertain. In this study, we conducted a bidirectional Mendelian randomization (MR) analysis at a summarized level to illuminate the potential causal relationship between the two variables. Methods: This study utilized genetic variance in cirrhosis and inflammatory cytokines from a genome-wide association study (GWAS) of European descent. The MR-PRESSO outlier test, Cochran’s Q test, and MR-Egger regression were applied to assess outliers, heterogeneity, and pleiotropy. The inverse variance weighted method and multiple sensitivity analyses were used to evaluate causalities. Furthermore, the validation set was used for simultaneous data validation. Results: The inflammatory cytokine monocyte chemoattractant protein 3 (MCP-3) was supposedly associated with a greater risk of cirrhosis. And cirrhosis was significantly correlated with increased levels of hepatocyte growth factor (HGF). Conclusions: This study suggests that MCP-3 might be associated with the etiology of cirrhosis, while several inflammatory cytokines could potentially play a role in its downstream development. Additionally, the progression of cirrhosis was associated with elevated levels of HGF, suggesting a possible role for liver repair functions.

5 August 2024 in Clinica Chimica Acta
Verified
Journal Article
Closed access
YZYanhua Zhao
Yanhua Zhao
HZHe Zhang
He Zhang
SLShanshan Liang
Shanshan Liang
YWYan Wang
Yan Wang
WGWei Gan*
Wei Gan*